Cargando…
Clinical data mining reveals Gancao-Banxia as a potential herbal pair against moderate COVID‐19 by dual binding to IL-6/STAT3
BACKGROUND: Coronavirus disease 2019 (COVID-19) keeps spreading globally. Chinese medicine (CM) exerts a critical role for the prevention or therapy of COVID-19 in an integrative and holistic way. However, mining and development of early, efficient, multisite binding CMs that inhibit the cytokine st...
Autores principales: | Luo, Weikang, Ding, Ruoqi, Guo, Xiaohang, Zhan, Tao, Tang, Tao, Fan, Rong, Wang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957363/ https://www.ncbi.nlm.nih.gov/pubmed/35366469 http://dx.doi.org/10.1016/j.compbiomed.2022.105457 |
Ejemplares similares
-
Pharmacokinetic incompatibility of the Huanglian-Gancao herb pair
por: Zhang, Ji-Quan, et al.
Publicado: (2020) -
Effects and Components of Herb Pair Huanglian-Banxia on Diabetic Gastroparesis by Network Pharmacology
por: Liang, Guoqiang, et al.
Publicado: (2021) -
Herbal medicine (Gancao Xiexin decoction) for Behcet disease: A systematic review protocol
por: Wu, Dongjie, et al.
Publicado: (2018) -
Herbal medicine, Banxia-xiexin tang, for functional dyspepsia: a systematic review and meta-analysis
por: Kim, Keumji, et al.
Publicado: (2023) -
Gancao (Glycyrrhizae Radix) provides the main contribution to Shaoyao-Gancao decoction on enhancements of CYP3A4 and MDR1 expression via pregnane X receptor pathway in vitro
por: Feng, Dandan, et al.
Publicado: (2018)